Treatment

test

Home Away from Home: Cancer Treatment and Lodging Help

To save money, more and more procedures are performed today on an out-patient basis, often including same-day surgical care. On-going treatments, like radiation or chemotherapy, may not require overnight hospitalization, but usually involve a series of exhausting treatments for patients, especially if daily-round trips to the hospital are required.

The Future of Lymphoma Research, part 2

Lymphoma research is moving forward in several distinct ways. The Coalition of Cancer Cooperative Groups highlights a few more potential successes.

Immunotherapy
Many new antibodies are being developed that boost the body’s natural defenses against cancer. Some use antibodies that attach to the surface of tumor cells. Some have radioactive substances attached that can direct radiation treatment to the lymphoma. This form of treatment is known as radioimmunotherapy.

The Future of Lymphoma Research

Lymphoma research is moving forward in several distinct ways. The Coalition of Cancer Cooperative Groups highlights a few potential successes.

Questions to Ask when Considering a Lymphoma Clinical Trial

Who can participate in this trial?

What are the eligibility requirements?

How do the potential benefits compare to other treatment options?

What are the trial’s tests and treatments?

How long will the trial last?

How will the trial and its possible side effects affect my daily life?

Are there treatments to help alleviate side effects?

Will my insurance company cover my costs?

Who will monitor my care and safety?

Who will review the information collected during the trial?

Searching for Lymphoma Clinical Trials?

The Lymphoma Research Foundation offers these suggestions for navigating the hundreds of lymphoma clinical trial options you may come across.

Eggplant Cures Cancer? Maybe Not

Dr. Bill Cham has a new book out called The Eggplant Cancer Cure; his website is EggplantCancerCure.com. According to the web site, "Dr. Cham has found substances which can penetrate and kill skin cancer cells but can’t penetrate normal skin cells, so normal skin cells are untouched and unhurt while the skin cancer cells die!" He claims to have conducted extensive studies on a cream he made (called Curaderm), which contains substances derived from eggplant.

Study finds Green Tea Blocks Benefits of Cancer Drug

The widely used supplement renders a specific drug used to treat multiple myeloma and mantle cell lymphoma ineffective in animal model

Contrary to popular assumptions about the health benefits of green tea, researchers at the University of Southern California (USC) have found that the widely used supplement renders a cancer drug used to treat multiple myeloma and mantle cell lymphoma completely ineffective in treating cancer.

The Future of Lymphoma Treatment? Personalized Care

For many cancer patients, chemotherapy can be worse than cancer itself. A patient may respond to one drug but not another, or the tumor may mutate and stop responding to the drug, resulting in months of wasted time, ineffective treatment and toxic side effects.

New Lymphoma Drug on Horizon

Allos Therapeutics reported that patients with a rare but aggressive form of blood cancer responded to treatment with the company's experimental drug pralatrexate for more than nine months. The result signifies that pralatrexate is having a meaningful benefit for patients, Allos said, and supports the company's effort to get the drug approved in the U.S. later this year. ralatrexate, or perhaps, sell the company outright to a larger drug firm.

Check out these New Clinical Trials

1. Phase I-II Multicenter, Open-Label Study of AEG35156 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

Aegera's antisense compound AEG35156 has shown early evidence of activity in patients with advanced indolent B-cell lymphomas in Phase I trials and merits further evaluation in this disease. This trial is designed to determine the recommended dose of AEG35156 in patients with relapse d or refractory chronic lymphocytic leukemia (CLL) and indolent B-cell lymphomas.